The cancellation or postponement of procedures due to the COVID-19 pandemic will have a significant negative impact on the Latin American market for aesthetic injectables in the short term. Once the situation improves, however, the market will resume strong growth, driven by high levels of aesthetic consciousness, marketing efforts from the major players, and an expanding patient pool.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectables in Latin America across a 10-year period.
The emergence of COVID-19 is affecting the aesthetic injectable market in the short term.
How will COVID-19 affect procedure volumes?
What will be the impact on market dynamics?
What strategies can companies use to remain successful in this market?
The dermal filler market has a greater revenue share in the Latin American aesthetic injectable market.
What are the drivers and limiters of the aesthetic injectable market?
What is the variation across procedure shares and revenue shares for dermal filler and BTX market?
Large MNCs will maintain their dominant positions in the market over the forecast period.
How do the most established competitors in this market maintain market share?
What strategies can new competitors employ to gain entry into the Latin American aesthetic injectable market?
- Aesthetic Injectables - Market Insights - Latin America
Author(s): Meenu Sankar, MS
Meenu Sankar is an analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in large-joint reconstructive implants. Meenu holds a Bachelor's degree in Pharmaceutical Sciences from Manipal University and a Master's degree in Biomedicine from The University of Skövde.
Follow Meenu on Twitter:@meenu_sankarDRG